9F7-F11

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug Name9F7-F11

Drug Alias Name9F7-F11

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody

Mechanisms of ActionReceptor tyrosine-protein kinase erbB-3 antagonistsAntibody-dependent cell-mediated cytotoxicity (ADCC) effectsNeuregulin-1 inhibitors

TargetsReceptor tyrosine-protein kinase erbB-3Neuregulin-1

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesInserm

China Registration ClassN/A

Develop Information

Active CompaniesInserm

Inactive CompaniesN/A

Active IndicationsNeoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A